Global Biosimilar Monoclonal Antibody Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Biosimilar Monoclonal Antibody market size was valued at US$ 4411.1 million in 2023. With growing demand in downstream market, the Biosimilar Monoclonal Antibody is forecast to a readjusted size of US$ 5622.5 million by 2030 with a CAGR of 3.5% during review period.
The research report highlights the growth potential of the global Biosimilar Monoclonal Antibody market. Biosimilar Monoclonal Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biosimilar Monoclonal Antibody. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biosimilar Monoclonal Antibody market.
Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.
Biosimilar Monoclonal Antibodies refer to the biologic medical product that are almost an identical copy of the original monoclonal antibodies but manufactured by a different company.
Global Biosimilar Monoclonal Antibodies key players include Celltrion, 3SBIO, Pfizer (Hospira), Novartis (Sandoz), etc. Global top four manufacturers hold a share nearly 85%.
Europe is the largest market, with a share about 40%, followed by China, and United States, both have a share about 50 percent.
In terms of product, Infliximab is the largest segment, with a share nearly 40%. And in terms of application, the largest application is Autoimmune Disease, followed by Oncology, etc.
Key Features:
The report on Biosimilar Monoclonal Antibody market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biosimilar Monoclonal Antibody market. It may include historical data, market segmentation by Type (e.g., Limited Dilution Method, Micromanipulation), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biosimilar Monoclonal Antibody market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biosimilar Monoclonal Antibody market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biosimilar Monoclonal Antibody industry. This include advancements in Biosimilar Monoclonal Antibody technology, Biosimilar Monoclonal Antibody new entrants, Biosimilar Monoclonal Antibody new investment, and other innovations that are shaping the future of Biosimilar Monoclonal Antibody.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biosimilar Monoclonal Antibody market. It includes factors influencing customer ' purchasing decisions, preferences for Biosimilar Monoclonal Antibody product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biosimilar Monoclonal Antibody market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biosimilar Monoclonal Antibody market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biosimilar Monoclonal Antibody market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biosimilar Monoclonal Antibody industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biosimilar Monoclonal Antibody market.
Market Segmentation:
Biosimilar Monoclonal Antibody market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Biosimilar Monoclonal Antibody market size was valued at US$ 4411.1 million in 2023. With growing demand in downstream market, the Biosimilar Monoclonal Antibody is forecast to a readjusted size of US$ 5622.5 million by 2030 with a CAGR of 3.5% during review period.
The research report highlights the growth potential of the global Biosimilar Monoclonal Antibody market. Biosimilar Monoclonal Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biosimilar Monoclonal Antibody. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biosimilar Monoclonal Antibody market.
Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.
Biosimilar Monoclonal Antibodies refer to the biologic medical product that are almost an identical copy of the original monoclonal antibodies but manufactured by a different company.
Global Biosimilar Monoclonal Antibodies key players include Celltrion, 3SBIO, Pfizer (Hospira), Novartis (Sandoz), etc. Global top four manufacturers hold a share nearly 85%.
Europe is the largest market, with a share about 40%, followed by China, and United States, both have a share about 50 percent.
In terms of product, Infliximab is the largest segment, with a share nearly 40%. And in terms of application, the largest application is Autoimmune Disease, followed by Oncology, etc.
Key Features:
The report on Biosimilar Monoclonal Antibody market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biosimilar Monoclonal Antibody market. It may include historical data, market segmentation by Type (e.g., Limited Dilution Method, Micromanipulation), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biosimilar Monoclonal Antibody market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biosimilar Monoclonal Antibody market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biosimilar Monoclonal Antibody industry. This include advancements in Biosimilar Monoclonal Antibody technology, Biosimilar Monoclonal Antibody new entrants, Biosimilar Monoclonal Antibody new investment, and other innovations that are shaping the future of Biosimilar Monoclonal Antibody.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biosimilar Monoclonal Antibody market. It includes factors influencing customer ' purchasing decisions, preferences for Biosimilar Monoclonal Antibody product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biosimilar Monoclonal Antibody market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biosimilar Monoclonal Antibody market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biosimilar Monoclonal Antibody market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biosimilar Monoclonal Antibody industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biosimilar Monoclonal Antibody market.
Market Segmentation:
Biosimilar Monoclonal Antibody market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Limited Dilution Method
- Micromanipulation
- Soft Agar Plate Method
- Others
- Chronic & Autoimmune Diseases
- Oncology
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biocon
- Accord Healthcare
- AET Biotech
- Amgen
- Celltrion
- Reddy's Laboratories
- Hospira
- 3SBio
- Allergan
- Alvartis
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biosimilar Monoclonal Antibody Market Size 2019-2030
2.1.2 Biosimilar Monoclonal Antibody Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biosimilar Monoclonal Antibody Segment by Type
2.2.1 Limited Dilution Method
2.2.2 Micromanipulation
2.2.3 Soft Agar Plate Method
2.2.4 Others
2.3 Biosimilar Monoclonal Antibody Market Size by Type
2.3.1 Biosimilar Monoclonal Antibody Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biosimilar Monoclonal Antibody Market Size Market Share by Type (2019-2024)
2.4 Biosimilar Monoclonal Antibody Segment by Application
2.4.1 Chronic & Autoimmune Diseases
2.4.2 Oncology
2.4.3 Others
2.5 Biosimilar Monoclonal Antibody Market Size by Application
2.5.1 Biosimilar Monoclonal Antibody Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biosimilar Monoclonal Antibody Market Size Market Share by Application (2019-2024)
3 BIOSIMILAR MONOCLONAL ANTIBODY MARKET SIZE BY PLAYER
3.1 Biosimilar Monoclonal Antibody Market Size Market Share by Players
3.1.1 Global Biosimilar Monoclonal Antibody Revenue by Players (2019-2024)
3.1.2 Global Biosimilar Monoclonal Antibody Revenue Market Share by Players (2019-2024)
3.2 Global Biosimilar Monoclonal Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOSIMILAR MONOCLONAL ANTIBODY BY REGIONS
4.1 Biosimilar Monoclonal Antibody Market Size by Regions (2019-2024)
4.2 Americas Biosimilar Monoclonal Antibody Market Size Growth (2019-2024)
4.3 APAC Biosimilar Monoclonal Antibody Market Size Growth (2019-2024)
4.4 Europe Biosimilar Monoclonal Antibody Market Size Growth (2019-2024)
4.5 Middle East & Africa Biosimilar Monoclonal Antibody Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biosimilar Monoclonal Antibody Market Size by Country (2019-2024)
5.2 Americas Biosimilar Monoclonal Antibody Market Size by Type (2019-2024)
5.3 Americas Biosimilar Monoclonal Antibody Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilar Monoclonal Antibody Market Size by Region (2019-2024)
6.2 APAC Biosimilar Monoclonal Antibody Market Size by Type (2019-2024)
6.3 APAC Biosimilar Monoclonal Antibody Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biosimilar Monoclonal Antibody by Country (2019-2024)
7.2 Europe Biosimilar Monoclonal Antibody Market Size by Type (2019-2024)
7.3 Europe Biosimilar Monoclonal Antibody Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biosimilar Monoclonal Antibody by Region (2019-2024)
8.2 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Type (2019-2024)
8.3 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOSIMILAR MONOCLONAL ANTIBODY MARKET FORECAST
10.1 Global Biosimilar Monoclonal Antibody Forecast by Regions (2025-2030)
10.1.1 Global Biosimilar Monoclonal Antibody Forecast by Regions (2025-2030)
10.1.2 Americas Biosimilar Monoclonal Antibody Forecast
10.1.3 APAC Biosimilar Monoclonal Antibody Forecast
10.1.4 Europe Biosimilar Monoclonal Antibody Forecast
10.1.5 Middle East & Africa Biosimilar Monoclonal Antibody Forecast
10.2 Americas Biosimilar Monoclonal Antibody Forecast by Country (2025-2030)
10.2.1 United States Biosimilar Monoclonal Antibody Market Forecast
10.2.2 Canada Biosimilar Monoclonal Antibody Market Forecast
10.2.3 Mexico Biosimilar Monoclonal Antibody Market Forecast
10.2.4 Brazil Biosimilar Monoclonal Antibody Market Forecast
10.3 APAC Biosimilar Monoclonal Antibody Forecast by Region (2025-2030)
10.3.1 China Biosimilar Monoclonal Antibody Market Forecast
10.3.2 Japan Biosimilar Monoclonal Antibody Market Forecast
10.3.3 Korea Biosimilar Monoclonal Antibody Market Forecast
10.3.4 Southeast Asia Biosimilar Monoclonal Antibody Market Forecast
10.3.5 India Biosimilar Monoclonal Antibody Market Forecast
10.3.6 Australia Biosimilar Monoclonal Antibody Market Forecast
10.4 Europe Biosimilar Monoclonal Antibody Forecast by Country (2025-2030)
10.4.1 Germany Biosimilar Monoclonal Antibody Market Forecast
10.4.2 France Biosimilar Monoclonal Antibody Market Forecast
10.4.3 UK Biosimilar Monoclonal Antibody Market Forecast
10.4.4 Italy Biosimilar Monoclonal Antibody Market Forecast
10.4.5 Russia Biosimilar Monoclonal Antibody Market Forecast
10.5 Middle East & Africa Biosimilar Monoclonal Antibody Forecast by Region (2025-2030)
10.5.1 Egypt Biosimilar Monoclonal Antibody Market Forecast
10.5.2 South Africa Biosimilar Monoclonal Antibody Market Forecast
10.5.3 Israel Biosimilar Monoclonal Antibody Market Forecast
10.5.4 Turkey Biosimilar Monoclonal Antibody Market Forecast
10.5.5 GCC Countries Biosimilar Monoclonal Antibody Market Forecast
10.6 Global Biosimilar Monoclonal Antibody Forecast by Type (2025-2030)
10.7 Global Biosimilar Monoclonal Antibody Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Biocon
11.1.1 Biocon Company Information
11.1.2 Biocon Biosimilar Monoclonal Antibody Product Offered
11.1.3 Biocon Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Biocon Main Business Overview
11.1.5 Biocon Latest Developments
11.2 Accord Healthcare
11.2.1 Accord Healthcare Company Information
11.2.2 Accord Healthcare Biosimilar Monoclonal Antibody Product Offered
11.2.3 Accord Healthcare Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Accord Healthcare Main Business Overview
11.2.5 Accord Healthcare Latest Developments
11.3 AET Biotech
11.3.1 AET Biotech Company Information
11.3.2 AET Biotech Biosimilar Monoclonal Antibody Product Offered
11.3.3 AET Biotech Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AET Biotech Main Business Overview
11.3.5 AET Biotech Latest Developments
11.4 Amgen
11.4.1 Amgen Company Information
11.4.2 Amgen Biosimilar Monoclonal Antibody Product Offered
11.4.3 Amgen Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Amgen Main Business Overview
11.4.5 Amgen Latest Developments
11.5 Celltrion
11.5.1 Celltrion Company Information
11.5.2 Celltrion Biosimilar Monoclonal Antibody Product Offered
11.5.3 Celltrion Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Celltrion Main Business Overview
11.5.5 Celltrion Latest Developments
11.6 Reddy's Laboratories
11.6.1 Reddy's Laboratories Company Information
11.6.2 Reddy's Laboratories Biosimilar Monoclonal Antibody Product Offered
11.6.3 Reddy's Laboratories Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Reddy's Laboratories Main Business Overview
11.6.5 Reddy's Laboratories Latest Developments
11.7 Hospira
11.7.1 Hospira Company Information
11.7.2 Hospira Biosimilar Monoclonal Antibody Product Offered
11.7.3 Hospira Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Hospira Main Business Overview
11.7.5 Hospira Latest Developments
11.8 3SBio
11.8.1 3SBio Company Information
11.8.2 3SBio Biosimilar Monoclonal Antibody Product Offered
11.8.3 3SBio Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 3SBio Main Business Overview
11.8.5 3SBio Latest Developments
11.9 Allergan
11.9.1 Allergan Company Information
11.9.2 Allergan Biosimilar Monoclonal Antibody Product Offered
11.9.3 Allergan Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Allergan Main Business Overview
11.9.5 Allergan Latest Developments
11.10 Alvartis
11.10.1 Alvartis Company Information
11.10.2 Alvartis Biosimilar Monoclonal Antibody Product Offered
11.10.3 Alvartis Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Alvartis Main Business Overview
11.10.5 Alvartis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biosimilar Monoclonal Antibody Market Size 2019-2030
2.1.2 Biosimilar Monoclonal Antibody Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biosimilar Monoclonal Antibody Segment by Type
2.2.1 Limited Dilution Method
2.2.2 Micromanipulation
2.2.3 Soft Agar Plate Method
2.2.4 Others
2.3 Biosimilar Monoclonal Antibody Market Size by Type
2.3.1 Biosimilar Monoclonal Antibody Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biosimilar Monoclonal Antibody Market Size Market Share by Type (2019-2024)
2.4 Biosimilar Monoclonal Antibody Segment by Application
2.4.1 Chronic & Autoimmune Diseases
2.4.2 Oncology
2.4.3 Others
2.5 Biosimilar Monoclonal Antibody Market Size by Application
2.5.1 Biosimilar Monoclonal Antibody Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biosimilar Monoclonal Antibody Market Size Market Share by Application (2019-2024)
3 BIOSIMILAR MONOCLONAL ANTIBODY MARKET SIZE BY PLAYER
3.1 Biosimilar Monoclonal Antibody Market Size Market Share by Players
3.1.1 Global Biosimilar Monoclonal Antibody Revenue by Players (2019-2024)
3.1.2 Global Biosimilar Monoclonal Antibody Revenue Market Share by Players (2019-2024)
3.2 Global Biosimilar Monoclonal Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOSIMILAR MONOCLONAL ANTIBODY BY REGIONS
4.1 Biosimilar Monoclonal Antibody Market Size by Regions (2019-2024)
4.2 Americas Biosimilar Monoclonal Antibody Market Size Growth (2019-2024)
4.3 APAC Biosimilar Monoclonal Antibody Market Size Growth (2019-2024)
4.4 Europe Biosimilar Monoclonal Antibody Market Size Growth (2019-2024)
4.5 Middle East & Africa Biosimilar Monoclonal Antibody Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biosimilar Monoclonal Antibody Market Size by Country (2019-2024)
5.2 Americas Biosimilar Monoclonal Antibody Market Size by Type (2019-2024)
5.3 Americas Biosimilar Monoclonal Antibody Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilar Monoclonal Antibody Market Size by Region (2019-2024)
6.2 APAC Biosimilar Monoclonal Antibody Market Size by Type (2019-2024)
6.3 APAC Biosimilar Monoclonal Antibody Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biosimilar Monoclonal Antibody by Country (2019-2024)
7.2 Europe Biosimilar Monoclonal Antibody Market Size by Type (2019-2024)
7.3 Europe Biosimilar Monoclonal Antibody Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biosimilar Monoclonal Antibody by Region (2019-2024)
8.2 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Type (2019-2024)
8.3 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOSIMILAR MONOCLONAL ANTIBODY MARKET FORECAST
10.1 Global Biosimilar Monoclonal Antibody Forecast by Regions (2025-2030)
10.1.1 Global Biosimilar Monoclonal Antibody Forecast by Regions (2025-2030)
10.1.2 Americas Biosimilar Monoclonal Antibody Forecast
10.1.3 APAC Biosimilar Monoclonal Antibody Forecast
10.1.4 Europe Biosimilar Monoclonal Antibody Forecast
10.1.5 Middle East & Africa Biosimilar Monoclonal Antibody Forecast
10.2 Americas Biosimilar Monoclonal Antibody Forecast by Country (2025-2030)
10.2.1 United States Biosimilar Monoclonal Antibody Market Forecast
10.2.2 Canada Biosimilar Monoclonal Antibody Market Forecast
10.2.3 Mexico Biosimilar Monoclonal Antibody Market Forecast
10.2.4 Brazil Biosimilar Monoclonal Antibody Market Forecast
10.3 APAC Biosimilar Monoclonal Antibody Forecast by Region (2025-2030)
10.3.1 China Biosimilar Monoclonal Antibody Market Forecast
10.3.2 Japan Biosimilar Monoclonal Antibody Market Forecast
10.3.3 Korea Biosimilar Monoclonal Antibody Market Forecast
10.3.4 Southeast Asia Biosimilar Monoclonal Antibody Market Forecast
10.3.5 India Biosimilar Monoclonal Antibody Market Forecast
10.3.6 Australia Biosimilar Monoclonal Antibody Market Forecast
10.4 Europe Biosimilar Monoclonal Antibody Forecast by Country (2025-2030)
10.4.1 Germany Biosimilar Monoclonal Antibody Market Forecast
10.4.2 France Biosimilar Monoclonal Antibody Market Forecast
10.4.3 UK Biosimilar Monoclonal Antibody Market Forecast
10.4.4 Italy Biosimilar Monoclonal Antibody Market Forecast
10.4.5 Russia Biosimilar Monoclonal Antibody Market Forecast
10.5 Middle East & Africa Biosimilar Monoclonal Antibody Forecast by Region (2025-2030)
10.5.1 Egypt Biosimilar Monoclonal Antibody Market Forecast
10.5.2 South Africa Biosimilar Monoclonal Antibody Market Forecast
10.5.3 Israel Biosimilar Monoclonal Antibody Market Forecast
10.5.4 Turkey Biosimilar Monoclonal Antibody Market Forecast
10.5.5 GCC Countries Biosimilar Monoclonal Antibody Market Forecast
10.6 Global Biosimilar Monoclonal Antibody Forecast by Type (2025-2030)
10.7 Global Biosimilar Monoclonal Antibody Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Biocon
11.1.1 Biocon Company Information
11.1.2 Biocon Biosimilar Monoclonal Antibody Product Offered
11.1.3 Biocon Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Biocon Main Business Overview
11.1.5 Biocon Latest Developments
11.2 Accord Healthcare
11.2.1 Accord Healthcare Company Information
11.2.2 Accord Healthcare Biosimilar Monoclonal Antibody Product Offered
11.2.3 Accord Healthcare Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Accord Healthcare Main Business Overview
11.2.5 Accord Healthcare Latest Developments
11.3 AET Biotech
11.3.1 AET Biotech Company Information
11.3.2 AET Biotech Biosimilar Monoclonal Antibody Product Offered
11.3.3 AET Biotech Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AET Biotech Main Business Overview
11.3.5 AET Biotech Latest Developments
11.4 Amgen
11.4.1 Amgen Company Information
11.4.2 Amgen Biosimilar Monoclonal Antibody Product Offered
11.4.3 Amgen Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Amgen Main Business Overview
11.4.5 Amgen Latest Developments
11.5 Celltrion
11.5.1 Celltrion Company Information
11.5.2 Celltrion Biosimilar Monoclonal Antibody Product Offered
11.5.3 Celltrion Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Celltrion Main Business Overview
11.5.5 Celltrion Latest Developments
11.6 Reddy's Laboratories
11.6.1 Reddy's Laboratories Company Information
11.6.2 Reddy's Laboratories Biosimilar Monoclonal Antibody Product Offered
11.6.3 Reddy's Laboratories Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Reddy's Laboratories Main Business Overview
11.6.5 Reddy's Laboratories Latest Developments
11.7 Hospira
11.7.1 Hospira Company Information
11.7.2 Hospira Biosimilar Monoclonal Antibody Product Offered
11.7.3 Hospira Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Hospira Main Business Overview
11.7.5 Hospira Latest Developments
11.8 3SBio
11.8.1 3SBio Company Information
11.8.2 3SBio Biosimilar Monoclonal Antibody Product Offered
11.8.3 3SBio Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 3SBio Main Business Overview
11.8.5 3SBio Latest Developments
11.9 Allergan
11.9.1 Allergan Company Information
11.9.2 Allergan Biosimilar Monoclonal Antibody Product Offered
11.9.3 Allergan Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Allergan Main Business Overview
11.9.5 Allergan Latest Developments
11.10 Alvartis
11.10.1 Alvartis Company Information
11.10.2 Alvartis Biosimilar Monoclonal Antibody Product Offered
11.10.3 Alvartis Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Alvartis Main Business Overview
11.10.5 Alvartis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biosimilar Monoclonal Antibody Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Limited Dilution Method
Table 3. Major Players of Micromanipulation
Table 4. Major Players of Soft Agar Plate Method
Table 5. Major Players of Others
Table 6. Biosimilar Monoclonal Antibody Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Biosimilar Monoclonal Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Biosimilar Monoclonal Antibody Market Size Market Share by Type (2019-2024)
Table 9. Biosimilar Monoclonal Antibody Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Biosimilar Monoclonal Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Biosimilar Monoclonal Antibody Market Size Market Share by Application (2019-2024)
Table 12. Global Biosimilar Monoclonal Antibody Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Biosimilar Monoclonal Antibody Revenue Market Share by Player (2019-2024)
Table 14. Biosimilar Monoclonal Antibody Key Players Head office and Products Offered
Table 15. Biosimilar Monoclonal Antibody Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Biosimilar Monoclonal Antibody Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Biosimilar Monoclonal Antibody Market Size Market Share by Regions (2019-2024)
Table 20. Global Biosimilar Monoclonal Antibody Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Biosimilar Monoclonal Antibody Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Biosimilar Monoclonal Antibody Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Biosimilar Monoclonal Antibody Market Size Market Share by Country (2019-2024)
Table 24. Americas Biosimilar Monoclonal Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Biosimilar Monoclonal Antibody Market Size Market Share by Type (2019-2024)
Table 26. Americas Biosimilar Monoclonal Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Biosimilar Monoclonal Antibody Market Size Market Share by Application (2019-2024)
Table 28. APAC Biosimilar Monoclonal Antibody Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Biosimilar Monoclonal Antibody Market Size Market Share by Region (2019-2024)
Table 30. APAC Biosimilar Monoclonal Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Biosimilar Monoclonal Antibody Market Size Market Share by Type (2019-2024)
Table 32. APAC Biosimilar Monoclonal Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Biosimilar Monoclonal Antibody Market Size Market Share by Application (2019-2024)
Table 34. Europe Biosimilar Monoclonal Antibody Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Biosimilar Monoclonal Antibody Market Size Market Share by Country (2019-2024)
Table 36. Europe Biosimilar Monoclonal Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Biosimilar Monoclonal Antibody Market Size Market Share by Type (2019-2024)
Table 38. Europe Biosimilar Monoclonal Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Biosimilar Monoclonal Antibody Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Biosimilar Monoclonal Antibody Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Biosimilar Monoclonal Antibody Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Biosimilar Monoclonal Antibody Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Biosimilar Monoclonal Antibody
Table 47. Key Market Challenges & Risks of Biosimilar Monoclonal Antibody
Table 48. Key Industry Trends of Biosimilar Monoclonal Antibody
Table 49. Global Biosimilar Monoclonal Antibody Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Biosimilar Monoclonal Antibody Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Biosimilar Monoclonal Antibody Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Biosimilar Monoclonal Antibody Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Biocon Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 54. Biocon Biosimilar Monoclonal Antibody Product Offered
Table 55. Biocon Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Biocon Main Business
Table 57. Biocon Latest Developments
Table 58. Accord Healthcare Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 59. Accord Healthcare Biosimilar Monoclonal Antibody Product Offered
Table 60. Accord Healthcare Main Business
Table 61. Accord Healthcare Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Accord Healthcare Latest Developments
Table 63. AET Biotech Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 64. AET Biotech Biosimilar Monoclonal Antibody Product Offered
Table 65. AET Biotech Main Business
Table 66. AET Biotech Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. AET Biotech Latest Developments
Table 68. Amgen Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 69. Amgen Biosimilar Monoclonal Antibody Product Offered
Table 70. Amgen Main Business
Table 71. Amgen Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Amgen Latest Developments
Table 73. Celltrion Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 74. Celltrion Biosimilar Monoclonal Antibody Product Offered
Table 75. Celltrion Main Business
Table 76. Celltrion Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Celltrion Latest Developments
Table 78. Reddy's Laboratories Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 79. Reddy's Laboratories Biosimilar Monoclonal Antibody Product Offered
Table 80. Reddy's Laboratories Main Business
Table 81. Reddy's Laboratories Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Reddy's Laboratories Latest Developments
Table 83. Hospira Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 84. Hospira Biosimilar Monoclonal Antibody Product Offered
Table 85. Hospira Main Business
Table 86. Hospira Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Hospira Latest Developments
Table 88. 3SBio Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 89. 3SBio Biosimilar Monoclonal Antibody Product Offered
Table 90. 3SBio Main Business
Table 91. 3SBio Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. 3SBio Latest Developments
Table 93. Allergan Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 94. Allergan Biosimilar Monoclonal Antibody Product Offered
Table 95. Allergan Main Business
Table 96. Allergan Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Allergan Latest Developments
Table 98. Alvartis Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 99. Alvartis Biosimilar Monoclonal Antibody Product Offered
Table 100. Alvartis Main Business
Table 101. Alvartis Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Alvartis Latest Developments
Table 1. Biosimilar Monoclonal Antibody Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Limited Dilution Method
Table 3. Major Players of Micromanipulation
Table 4. Major Players of Soft Agar Plate Method
Table 5. Major Players of Others
Table 6. Biosimilar Monoclonal Antibody Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Biosimilar Monoclonal Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Biosimilar Monoclonal Antibody Market Size Market Share by Type (2019-2024)
Table 9. Biosimilar Monoclonal Antibody Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Biosimilar Monoclonal Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Biosimilar Monoclonal Antibody Market Size Market Share by Application (2019-2024)
Table 12. Global Biosimilar Monoclonal Antibody Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Biosimilar Monoclonal Antibody Revenue Market Share by Player (2019-2024)
Table 14. Biosimilar Monoclonal Antibody Key Players Head office and Products Offered
Table 15. Biosimilar Monoclonal Antibody Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Biosimilar Monoclonal Antibody Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Biosimilar Monoclonal Antibody Market Size Market Share by Regions (2019-2024)
Table 20. Global Biosimilar Monoclonal Antibody Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Biosimilar Monoclonal Antibody Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Biosimilar Monoclonal Antibody Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Biosimilar Monoclonal Antibody Market Size Market Share by Country (2019-2024)
Table 24. Americas Biosimilar Monoclonal Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Biosimilar Monoclonal Antibody Market Size Market Share by Type (2019-2024)
Table 26. Americas Biosimilar Monoclonal Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Biosimilar Monoclonal Antibody Market Size Market Share by Application (2019-2024)
Table 28. APAC Biosimilar Monoclonal Antibody Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Biosimilar Monoclonal Antibody Market Size Market Share by Region (2019-2024)
Table 30. APAC Biosimilar Monoclonal Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Biosimilar Monoclonal Antibody Market Size Market Share by Type (2019-2024)
Table 32. APAC Biosimilar Monoclonal Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Biosimilar Monoclonal Antibody Market Size Market Share by Application (2019-2024)
Table 34. Europe Biosimilar Monoclonal Antibody Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Biosimilar Monoclonal Antibody Market Size Market Share by Country (2019-2024)
Table 36. Europe Biosimilar Monoclonal Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Biosimilar Monoclonal Antibody Market Size Market Share by Type (2019-2024)
Table 38. Europe Biosimilar Monoclonal Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Biosimilar Monoclonal Antibody Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Biosimilar Monoclonal Antibody Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Biosimilar Monoclonal Antibody Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Biosimilar Monoclonal Antibody Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Biosimilar Monoclonal Antibody
Table 47. Key Market Challenges & Risks of Biosimilar Monoclonal Antibody
Table 48. Key Industry Trends of Biosimilar Monoclonal Antibody
Table 49. Global Biosimilar Monoclonal Antibody Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Biosimilar Monoclonal Antibody Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Biosimilar Monoclonal Antibody Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Biosimilar Monoclonal Antibody Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Biocon Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 54. Biocon Biosimilar Monoclonal Antibody Product Offered
Table 55. Biocon Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Biocon Main Business
Table 57. Biocon Latest Developments
Table 58. Accord Healthcare Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 59. Accord Healthcare Biosimilar Monoclonal Antibody Product Offered
Table 60. Accord Healthcare Main Business
Table 61. Accord Healthcare Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Accord Healthcare Latest Developments
Table 63. AET Biotech Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 64. AET Biotech Biosimilar Monoclonal Antibody Product Offered
Table 65. AET Biotech Main Business
Table 66. AET Biotech Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. AET Biotech Latest Developments
Table 68. Amgen Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 69. Amgen Biosimilar Monoclonal Antibody Product Offered
Table 70. Amgen Main Business
Table 71. Amgen Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Amgen Latest Developments
Table 73. Celltrion Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 74. Celltrion Biosimilar Monoclonal Antibody Product Offered
Table 75. Celltrion Main Business
Table 76. Celltrion Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Celltrion Latest Developments
Table 78. Reddy's Laboratories Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 79. Reddy's Laboratories Biosimilar Monoclonal Antibody Product Offered
Table 80. Reddy's Laboratories Main Business
Table 81. Reddy's Laboratories Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Reddy's Laboratories Latest Developments
Table 83. Hospira Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 84. Hospira Biosimilar Monoclonal Antibody Product Offered
Table 85. Hospira Main Business
Table 86. Hospira Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Hospira Latest Developments
Table 88. 3SBio Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 89. 3SBio Biosimilar Monoclonal Antibody Product Offered
Table 90. 3SBio Main Business
Table 91. 3SBio Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. 3SBio Latest Developments
Table 93. Allergan Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 94. Allergan Biosimilar Monoclonal Antibody Product Offered
Table 95. Allergan Main Business
Table 96. Allergan Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Allergan Latest Developments
Table 98. Alvartis Details, Company Type, Biosimilar Monoclonal Antibody Area Served and Its Competitors
Table 99. Alvartis Biosimilar Monoclonal Antibody Product Offered
Table 100. Alvartis Main Business
Table 101. Alvartis Biosimilar Monoclonal Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Alvartis Latest Developments
LIST OF FIGURES
Figure 1. Biosimilar Monoclonal Antibody Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biosimilar Monoclonal Antibody Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Biosimilar Monoclonal Antibody Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biosimilar Monoclonal Antibody Sales Market Share by Country/Region (2023)
Figure 8. Biosimilar Monoclonal Antibody Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biosimilar Monoclonal Antibody Market Size Market Share by Type in 2023
Figure 10. Biosimilar Monoclonal Antibody in Chronic & Autoimmune Diseases
Figure 11. Global Biosimilar Monoclonal Antibody Market: Chronic & Autoimmune Diseases (2019-2024) & ($ Millions)
Figure 12. Biosimilar Monoclonal Antibody in Oncology
Figure 13. Global Biosimilar Monoclonal Antibody Market: Oncology (2019-2024) & ($ Millions)
Figure 14. Biosimilar Monoclonal Antibody in Others
Figure 15. Global Biosimilar Monoclonal Antibody Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Biosimilar Monoclonal Antibody Market Size Market Share by Application in 2023
Figure 17. Global Biosimilar Monoclonal Antibody Revenue Market Share by Player in 2023
Figure 18. Global Biosimilar Monoclonal Antibody Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Biosimilar Monoclonal Antibody Market Size 2019-2024 ($ Millions)
Figure 20. APAC Biosimilar Monoclonal Antibody Market Size 2019-2024 ($ Millions)
Figure 21. Europe Biosimilar Monoclonal Antibody Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Biosimilar Monoclonal Antibody Market Size 2019-2024 ($ Millions)
Figure 23. Americas Biosimilar Monoclonal Antibody Value Market Share by Country in 2023
Figure 24. United States Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Biosimilar Monoclonal Antibody Market Size Market Share by Region in 2023
Figure 29. APAC Biosimilar Monoclonal Antibody Market Size Market Share by Type in 2023
Figure 30. APAC Biosimilar Monoclonal Antibody Market Size Market Share by Application in 2023
Figure 31. China Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Biosimilar Monoclonal Antibody Market Size Market Share by Country in 2023
Figure 38. Europe Biosimilar Monoclonal Antibody Market Size Market Share by Type (2019-2024)
Figure 39. Europe Biosimilar Monoclonal Antibody Market Size Market Share by Application (2019-2024)
Figure 40. Germany Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Biosimilar Monoclonal Antibody Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Biosimilar Monoclonal Antibody Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Biosimilar Monoclonal Antibody Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 54. APAC Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 55. Europe Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 57. United States Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 58. Canada Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 61. China Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 62. Japan Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 63. Korea Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 65. India Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 66. Australia Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 67. Germany Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 68. France Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 69. UK Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 70. Italy Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 71. Russia Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 72. Spain Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 75. Israel Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 78. Global Biosimilar Monoclonal Antibody Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Biosimilar Monoclonal Antibody Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Biosimilar Monoclonal Antibody Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biosimilar Monoclonal Antibody Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Biosimilar Monoclonal Antibody Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biosimilar Monoclonal Antibody Sales Market Share by Country/Region (2023)
Figure 8. Biosimilar Monoclonal Antibody Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biosimilar Monoclonal Antibody Market Size Market Share by Type in 2023
Figure 10. Biosimilar Monoclonal Antibody in Chronic & Autoimmune Diseases
Figure 11. Global Biosimilar Monoclonal Antibody Market: Chronic & Autoimmune Diseases (2019-2024) & ($ Millions)
Figure 12. Biosimilar Monoclonal Antibody in Oncology
Figure 13. Global Biosimilar Monoclonal Antibody Market: Oncology (2019-2024) & ($ Millions)
Figure 14. Biosimilar Monoclonal Antibody in Others
Figure 15. Global Biosimilar Monoclonal Antibody Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Biosimilar Monoclonal Antibody Market Size Market Share by Application in 2023
Figure 17. Global Biosimilar Monoclonal Antibody Revenue Market Share by Player in 2023
Figure 18. Global Biosimilar Monoclonal Antibody Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Biosimilar Monoclonal Antibody Market Size 2019-2024 ($ Millions)
Figure 20. APAC Biosimilar Monoclonal Antibody Market Size 2019-2024 ($ Millions)
Figure 21. Europe Biosimilar Monoclonal Antibody Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Biosimilar Monoclonal Antibody Market Size 2019-2024 ($ Millions)
Figure 23. Americas Biosimilar Monoclonal Antibody Value Market Share by Country in 2023
Figure 24. United States Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Biosimilar Monoclonal Antibody Market Size Market Share by Region in 2023
Figure 29. APAC Biosimilar Monoclonal Antibody Market Size Market Share by Type in 2023
Figure 30. APAC Biosimilar Monoclonal Antibody Market Size Market Share by Application in 2023
Figure 31. China Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Biosimilar Monoclonal Antibody Market Size Market Share by Country in 2023
Figure 38. Europe Biosimilar Monoclonal Antibody Market Size Market Share by Type (2019-2024)
Figure 39. Europe Biosimilar Monoclonal Antibody Market Size Market Share by Application (2019-2024)
Figure 40. Germany Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Biosimilar Monoclonal Antibody Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Biosimilar Monoclonal Antibody Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Biosimilar Monoclonal Antibody Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Biosimilar Monoclonal Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 54. APAC Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 55. Europe Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 57. United States Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 58. Canada Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 61. China Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 62. Japan Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 63. Korea Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 65. India Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 66. Australia Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 67. Germany Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 68. France Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 69. UK Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 70. Italy Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 71. Russia Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 72. Spain Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 75. Israel Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Biosimilar Monoclonal Antibody Market Size 2025-2030 ($ Millions)
Figure 78. Global Biosimilar Monoclonal Antibody Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Biosimilar Monoclonal Antibody Market Size Market Share Forecast by Application (2025-2030)
